Website Logo

Search

Results for “”

Page

Contact

READ MORE

Page

ESG

READ MORE

Page

About Us

READ MORE

Page

Medical Affairs

READ MORE

Page

Biostatistics & Clinical Programming

READ MORE

Press Room

Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States

READ MORE

Page

Early Access Programs

READ MORE

Press Room

Bionical Emas launches Managed Access Program for JZP 458 – a recombinant Crisantaspase produced in Pseudomonas fluorescens

READ MORE

Press Room

Bionical Emas launches Expanded Access Program for JZP458 – a recombinant Erwinia Asparaginase

READ MORE

Press Room

Tom Watson appointed Chief Executive Officer

READ MORE

Page

A Career with Purpose

READ MORE

Page

Patient Advocacy

READ MORE

5 / 6